ICA Group Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

ICA Group Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$6.27K	Sell	267 -709	-73%	-$17.9K	﹤0.01%	553
2024 Q1	$28.1K	Sell	976 -1,047	-52%	-$31.5K	0.01%	678
2023 Q4	$66.4K	Buy	+2,023	New	+$55K	0.01%	449
2023 Q3	–	Sell	-4,746	Closed	-$162K	–	293
2023 Q2	$162K	Sell	4,746 -610	-11%	-$19.2K	0.04%	260
2023 Q1	$161K	Sell	5,356 -1,035	-16%	-$32.1K	0.04%	263
2022 Q4	$180K	Sell	6,391 -1,213	-16%	-$38.5K	0.04%	264
2022 Q3	$250K	Sell	7,604 -293	-4%	-$10.8K	0.05%	297
2022 Q2	$287K	Sell	7,897 -50	-0.6%	-$1.75K	0.05%	295
2022 Q1	$252K	Buy	+7,947	New	+$379K	0.05%	314

Other funds holding ARKG

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

ICA Group Wealth Management's ARKG Position: Q2 2024 in Review

ICA Group Wealth Management reduced its ARK Genomic Revolution ETF (ARKG) stake by 73% in Q2 2024, selling an estimated $17.9K and leaving 267 shares worth $6.27K. The position accounts for ﹤0.01% of the portfolio, ranked #553.

ICA Group Wealth Management first reported a position in ARKG in Q1 2022 and has held it in 9 quarters since. The position peaked at $287K in Q2 2022. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

ICA Group Wealth Management held 267 shares of ARK Genomic Revolution ETF worth $6.27K as of Q2 2024.
ICA Group Wealth Management sold 709 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $17.9K.
ARK Genomic Revolution ETF made up ﹤0.01% of ICA Group Wealth Management's portfolio in Q2 2024, its #553 holding.
ICA Group Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2022 and has held it in 9 quarters since.
ICA Group Wealth Management's ARK Genomic Revolution ETF position peaked at $287K in Q2 2022.
261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.